SORIN CRM SAS

Their core work

Sorin CRM (now part of LivaNova) is a French manufacturer of implantable cardiac rhythm management devices, including pacemakers, defibrillators, and cardiac leads. Within H2020 projects, they contribute industrial expertise in designing and testing cardiac implant hardware — from multi-electrode leads to wireless in-body communication systems. Their role in EU research is that of a medical device company pushing its products toward next-generation capabilities: smarter energy harvesting for implants, wireless body-area networks, and computational (in-silico) testing to accelerate regulatory approval of cardiac devices and therapies.

What they specialise in

How they've shifted over time

In their early H2020 participation (2014–2018), Sorin CRM focused on enabling technologies for implantable devices — miniaturized energy harvesting (smart-MEMPHIS) and wireless in-body communication (WiBEC) — building the component-level capabilities needed for next-generation implants. From 2017 onward, the focus shifted decisively toward the cardiac devices themselves: first with AXONE on commercial multi-electrode leads, then with SimCardioTest on computational simulation for regulatory approval. The trajectory shows a move from hardware component R&D toward digital validation and faster market access for cardiac products.

Sorin CRM is moving toward computational and in-silico methods to validate cardiac devices, positioning itself to reduce time-to-market through simulation-based regulatory pathways.

How they like to work

Sorin CRM primarily participates as a partner (3 of 4 projects), stepping into the coordinator role only for AXONE — their most commercially direct project on cardiac leads. With 32 unique partners across 10 countries, they integrate into mid-to-large European consortia rather than leading them, contributing industrial device expertise alongside academic and clinical partners. This profile suggests a company that is straightforward to work with as a use-case provider and end-user validator, rather than a consortium management hub.

Sorin CRM has worked with 32 distinct partners across 10 European countries, indicating a well-connected but not dominant network position. Their partnerships span academic institutions, clinical centers, and technology providers in the medical device and digital health ecosystems.

What sets them apart

Sorin CRM brings something rare to EU consortia: they are an actual manufacturer of implantable cardiac devices, not a research lab or consultancy. This means they can provide real-world device specifications, clinical use requirements, and a credible path to market for research results. For any project involving cardiac implants, in-body electronics, or medical device regulation, they offer the industrial endpoint that turns research into a product.

Highlights from their portfolio

• AXONE
  Their only coordinated project and largest single grant (EUR 1.37M), focused on commercial multi-electrode cardiac lead technology — directly tied to their core product line.
• SimCardioTest
  Most recent and strategically significant project (EUR 1.02M), representing their pivot toward in-silico testing and simulation-based regulatory approval for cardiac devices and drugs.